Form 4: SPX Technologies VP, CLO & Secretary, Cheree H. Johnson, Reports Stock and Option Grants
SEC Form 4 Filing
Cheree H. Johnson, VP, CLO & Secretary of SPX Technologies, reports the grant of restricted stock units and stock options.
Summary
- On March 3, 2025, Cheree H. Johnson, VP, CLO & Secretary of SPX Technologies, received restricted stock units and stock options.
- She was granted 3,414 shares of common stock as restricted stock units.
- She also received a grant of 2,576 stock options with an exercise price of $138.60, vesting in three equal installments beginning March 3, 2026, and expiring on March 3, 2035.
- Additionally, she holds 5,286 employee stock options with an exercise price of $139.19, vesting in three equal installments beginning July 1, 2025, and expiring on July 1, 2034.
- Following these transactions, Johnson directly owns 7,543 shares of common stock, including unvested restricted stock units, and indirectly owns 113 shares through a 401(k) plan.
Sentiment
Score: 6
Explanation: The document is a neutral disclosure of insider transactions. It doesn't inherently indicate positive or negative sentiment, but rather provides information about executive compensation and ownership.
Positives
- The grant of restricted stock units and stock options aligns Johnson's interests with those of the shareholders.
- The vesting schedules of the stock options incentivize continued service with the company.
Future Outlook
The document does not contain any specific forward-looking statements regarding the company's future performance.
Industry Context
This filing is a routine disclosure of insider transactions, which is common for publicly traded companies. It provides transparency into the compensation and equity ownership of key executives.
Comparison to Industry Standards
- Stock option and restricted stock unit grants are standard components of executive compensation packages in publicly traded companies.
- Vesting schedules are designed to retain key personnel and align their interests with long-term shareholder value.
- The specific terms of the grants (number of shares, exercise price, vesting schedule) would need to be compared to peer companies to assess their competitiveness.
Stakeholder Impact
- Shareholders can use this information to understand executive compensation practices.
- Employees may be interested in the equity ownership of company leadership.
Key Dates
| Date | Description |
|---|---|
| 03/03/2025 | Date of the reported transactions: grant of restricted stock units and stock options. |
| 03/03/2026 | First vesting date for the 2,576 stock options granted on 03/03/2025. |
| 03/03/2028 | Expiration date for the 2,576 stock options granted on 03/03/2025. |
| 03/03/2035 | Expiration date for the 2,576 stock options granted on 03/03/2025. |
| 07/01/2025 | First vesting date for the 5,286 stock options. |
| 07/01/2027 | Expiration date for the 5,286 stock options. |
| 07/01/2034 | Expiration date for the 5,286 stock options. |
| 03/05/2025 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.